As you might have noticed: During two days of public hearings starting on Tuesday, scientists were scheduled to present their research to outside advisers to the U.S. Food and Drug Administration. The agency will decide whether safety concerns raised by three-parent IVF are minimal enough to allow clinical trials to begin. More
This is a members-only post on Ricochet's Member Feed. Want to read it? Join Ricochet’s growing community of conservatives and be part of the conversation. Get your first month free.